ESSA Pharma Inc. Stock Toronto S.E.
Equities
EPI
CA29668H7085
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 379M 277M |
---|---|---|---|---|---|
Net income 2024 * | -48M -35.09M | Net income 2025 * | -78M -57.01M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.9
x | P/E ratio 2025 * |
-5.62
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.73% |
Latest transcript on ESSA Pharma Inc.
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
David Wood
DFI | Director of Finance/CFO | 66 | 13-09-30 |
Peter Virsik
COO | Chief Operating Officer | - | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 15-03-04 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 19-07-30 |
Richard Glickman
CHM | Chairman | 65 | 10-09-30 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.28% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |